Antibody Isotypes for Tumor Immunotherapy.

about

Antibody Engineering - Tailor-Made Next Generation Antibodies by Molecular Design.The effects of Antibody Engineering CH and CL in Trastuzumab and Pertuzumab recombinant models: Impact on antibody production and antigen-binding.

P2860

Q42660148-72D6F62B-7386-46B0-89C9-E469A92FC63F Q47731094-4883C31C-34B3-45FB-86E2-E6BB349A3C96

P2860

Antibody Isotypes for Tumor Immunotherapy.

Item

http://www.wikidata.org/entity/Q42660171

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Antibody Isotypes for Tumor Immunotherapy.

@en

Antibody Isotypes for Tumor Immunotherapy.

@nl

type

Item

label

Antibody Isotypes for Tumor Immunotherapy.

@en

Antibody Isotypes for Tumor Immunotherapy.

@nl

prefLabel

Antibody Isotypes for Tumor Immunotherapy.

@en

Antibody Isotypes for Tumor Immunotherapy.

@nl

P1476

Antibody Isotypes for Tumor Immunotherapy.

@en

P2093

Anna Kretschmer

http://www.w3.org/2001/XMLSchema#string

Ralf Schwanbeck

http://www.w3.org/2001/XMLSchema#string

Thies Rösner

http://www.w3.org/2001/XMLSchema#string

Thomas Valerius

http://www.w3.org/2001/XMLSchema#string

P2860

Influence of immunoglobulin isotype on therapeutic antibody function

The blockade of immune checkpoints in cancer immunotherapy

IgE immunotherapy against cancer

IgA Fc receptors

New nomenclature for Fc receptor-like molecules

Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study

Opening the door to innovation

Fc receptors for immunoglobulins and their appearance during vertebrate evolution

IgG subclass profiles in infected HIV type 1 controllers and chronic progressors and in uninfected recipients of Env vaccines.

Multiple roles for the major histocompatibility complex class I- related receptor FcRn.

P304

320-326

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000479240

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29070977

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

5649311

http://www.w3.org/2001/XMLSchema#string

Antibody Isotypes for Tumor Immunotherapy.

about

P2860

P2860

Antibody Isotypes for Tumor Immunotherapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932